Showing 61 - 80 results of 2,205 for search '"myelodysplastic syndrome"', query time: 0.68s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64

    Discovering transcription and splicing networks in myelodysplastic syndromes. by Hongyan Wang, Jianguo Wen, Chung-Che Chang, Xiaobo Zhou

    Published 2013-01-01
    “…Then, we applied this method to investigate the mechanism of myelodysplastic syndromes (MDS), a precursor lesion of acute myeloid leukemia. …”
    Get full text
    Article
  5. 65

    Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome? by Bruno Fattizzo, Fabio Serpenti, Wilma Barcellini, Chiara Caprioli

    Published 2021-01-01
    Subjects: “…hypoplastic myelodysplastic syndrome…”
    Get full text
    Article
  6. 66
  7. 67

    BMT for Myelodysplastic Syndrome: When and Where and How by Akriti G. Jain, Hany Elmariah

    Published 2022-01-01
    Subjects: “…myelodysplastic syndromes…”
    Get full text
    Article
  8. 68
  9. 69
  10. 70

    The genetics of myelodysplastic syndromes and the opportunities for tailored treatments by Christina-Nefeli Kontandreopoulou, Konstantinos Kalopisis, Nora-Athina Viniou, Panagiotis Diamantopoulos

    Published 2022-10-01
    “…Genomic instability, microenvironmental aberrations, and somatic mutations contribute to the phenotype of myelodysplastic syndrome and the risk for transformation to AML. …”
    Get full text
    Article
  11. 71
  12. 72
  13. 73

    When karyotype is decisive for myelodysplastic syndromes diagnosis by Aline dos Santos Borgo Perazzio, Maria de Lourdes L. Ferrari Chauffaille

    Published 2019-10-01
    “…Introduction: The myelodysplastic syndromes (MDS) are a group of heterogeneous clonal hematopoietic stem cell disorders that results in peripheral blood (PB) cytopenias and bone marrow (BM) dysplasia. …”
    Get full text
    Article
  14. 74
  15. 75

    Management of patients with lower-risk myelodysplastic syndromes by Andrew M. Brunner, Heather A. Leitch, Arjan A. van de Loosdrecht, Nicolas Bonadies

    Published 2022-12-01
    “…Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell disorders characterized by ineffective hematopoiesis with abnormal blood cell development (dysplasia) leading to cytopenias and an increased risk for progression to acute myeloid leukemia (AML). …”
    Get full text
    Article
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    The role of azacitidine in the management of myelodysplastic syndromes (MDS) by KS Götze, C Müller-Thomas, C Peschel

    Published 2009-10-01
    “…Current data on azacitidine and its place in the treatment of MDS are reviewed.Keywords: myelodysplastic syndromes, MDS, azacitidine, epigenetic therapy, demethyltransferase inhibitor…”
    Get full text
    Article